Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 901–1,000 of 3,349
The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after?
Gabrielli, M., Raffaele, S., Fumagalli, M., & Verderio, C. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.984690 · Cited by 61
CSMD1 regulates brain complement activity and circuit development
Baum, M. L., Wilton, D. K., Fox, R. G., Carey, A. E., Hsu, Y.-H. H., Hu, R., Jäntti, H., Fahey, J. B., Muthukumar, A. K., Salla, N., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.041 · Cited by 52
“…models of brain disease in which enhanced complement activity and microglial synaptic elimination are implicated, including Alzheimer ’ s disease, Huntington ’ s disease and West Nile virus-induced memory impairment (Hong et al., 2016; Schafer et al., 2016; Vasek et al., 2016; Wilton et al., 2023).”
BackgroundSelf-citationHigh-fat diet and neuroinflammation: The role of mitochondria
Song, M., Bai, Y., & Song, F. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107615 · Cited by 64
Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?
Murphy, K. E., & Park, J. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061168 · Cited by 53
“Moreover, Aβ peptide oligomers infuriates microglial cells that, in turn, release free radicals and inflammatory cytokines [5].”
BackgroundMagro‐Checa, C., Steup‐Beekman, G. M., Huizinga, T. W. J., van Buchem, M. A., & Ronen, I. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00340 · Cited by 52
“Recent discoveries on mouse models of Alzheimer’s disease confirmed a critical role of the classical complement cascade in early synapse loss (19, 20).”
BackgroundReichert, F., & Rotshenker, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00090 · Cited by 54
Frost, P. S., Barros‐Aragão, F. G. Q., da Silva, R. T., Venancio, A. M., Matias, I. C. P., Silva, N. M. L. E., Kincheski, G. C., Pimentel‐Coelho, P. M., Felice, F. G. D., Gomes, F. C. A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1529-x · Cited by 55
Late-in-life neurodegeneration after chronic sleep loss in young adult mice
Owen, J. E., Zhu, Y., Fenik, P., Zhan, G., Bell, P., Liu, X. C., & Veasey, S. C. (2021) · SLEEP · doi:10.1093/sleep/zsab057 · Cited by 59
“Prior to the development of amyloid plaque in mouse models of AD, a punctate pattern of A β 42 may be observed in several brain regions including the HC in AD transgenic mice [46], suggesting that this punctate pattern of A β 42 in CA1 is a pre-plaque finding in AD.”
BackgroundDing, W., Lin, H., Hong, X., Ji, D., & Wu, F. (2020) · Toxicology · doi:10.1016/j.tox.2020.152437 · Cited by 50
Hohsfield, L. A., Najafi, A. R., Ghorbanian, Y., Soni, N., Crapser, J., Figueroa Velez, D. X., Jiang, S., Royer, S. E., Kim, S. J., Henningfield, C. M., et al. (2021) · eLife · doi:10.7554/elife.66738 · Cited by 48
Biomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease
Chu, J., Zhang, W., Liu, Y., Gong, B., Ji, W., Yin, T., Gao, C., Liangwen, D., Hao, M., Chen, C., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374137 · Cited by 53
“…also inhibits Aβ-induced neuroinflammatory response in astrocytes by suppressing NLRP3 inflammasome activation and the double-stranded RNA-dependent protein kinase-like endoplasmic reticulum kinase/eukaryotic initiation factor 2α-dependent endoplasmic reticulum stress (Hong et al., 2016b, 2019).”
Tillmon, H., Soteros, B. M., Shen, L., Cong, Q., Wollet, M., General, J., Chin, H., Lee, J. B., Carreno, F. R., Morilak, D. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54007-5 · Cited by 68
Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain
Yousefpour, N., Tansley, S. N., Locke, S., Sharif, B., Parisien, M., Bourojeni, F. B., Deamond, H., Mathur, V., Arana, N. R.-K., Austin, J. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59849-1 · Cited by 56
“C1q levelsaretightly regulatedintheadultCNS, while injury, normalaging, or certain diseases increase C1q expression 16,28,29 .”
Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 79
Association of Cancer History with Alzheimer’s Disease Dementia and Neuropathology
Yarchoan, M., James, B. D., Shah, R. C., Arvanitakis, Z., Wilson, R. S., Schneider, J., Bennett, D. A., & Arnold, S. E. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160977 · Cited by 47
“As both cancer and AD have been hypothesized to represent failures of the immune system [30, 31], it is possible that immune function could mediate enhanced survival from cancer and resilience in AD.”
Nitkiewicz, J., Borjabad, A., Morgello, S., Murray, J., Chao, W., Emdad, L., Fisher, P. B., Potash, M. J., & Volsky, D. J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0794-9 · Cited by 53
“Synaptic loss in a mouse model of Alzheimer’s disease has been linked to aberrant expression of C1q which was further shown essential for soluble β amyloid synaptic toxicity [47]; in mice, West Nile virus infection of neurons drives their expression of complement components leading to pruning of presynaptic termini, a…”
BackgroundThe P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illes, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 48
“in Aβ transgenic mouse models and after injection of oligomeric Aβ into the lateral ventricle of mice may result in neurotoxicity [78,79].”
BackgroundComplement and CD4+ T cells drive context-specific corneal sensory neuropathy
Royer, D. J., Echegaray-Mendez, J., Lin, L., Gmyrek, G. B., Mathew, R., Saban, D. R., Perez, V. L., & Carr, D. J. J. (2019) · eLife · doi:10.7554/elife.48378 · Cited by 50
Morgan, B. P., Gommerman, J. L., & Ramaglia, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.600656 · Cited by 60
“…at synapses before overt plaque deposition, whereas deletion of C1q or C3 or the complement receptor CR3 (also expressed on microglia), reduced the number of phagocytic microglia as well as the extent of early synapse loss, resulting in improved cognitive function (Hong et al., 2016; Figure 2B).”
BackgroundThe Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
Yin, X., Qiu, Y., Zhao, C., Zhou, Z., Bao, J., & Qian, W. (2021) · Medical Science Monitor · doi:10.12659/msm.933084 · Cited by 48
“It has been reported that the expression of PSD-95 is aberrant in several human disorders, including AD [61-65].”
BackgroundChatterjee, M., Özdemir, S., Kunadt, M., Koel‐Simmelink, M., Boiten, W., Piepkorn, L., Pham, T. V., Chiasserini, D., Piersma, S. R., Knol, J. C., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13066 · Cited by 47
Merle, N. S., Boudhabhay, I., Léon, J., Frémeaux‐Bacchi, V., & Roumenina, L. T. (2019) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2019.02.008 · Cited by 51
Borucki, D. M., Toutonji, A., Couch, C., Mallah, K., Rohrer, B., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566892 · Cited by 50
“CR3-mediated phagocytosis is also implicated in synaptic phagocytosis in the APP mouse model, suggesting that the same pathway leading to clearance of Aβ is also involved in synapse loss (28).”
BackgroundThe plasma peptides of Alzheimer’s disease
Florentinus-Mefailoski, A., Bowden, P., Scheltens, P., Killestein, J., Teunissen, C. E., & Marshall, J. G. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09320-2 · Cited by 45
The role of the complement system in Multiple Sclerosis: A review
Saez-Calveras, N., & Stüve, O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970486 · Cited by 57
“hAPP Decreased phagocytic microglia, decreased early synapse loss (20) Mice equally susceptible to EAE.”
BackgroundInfluentialPenney, J., Ralvenius, W. T., Loon, A., Cerit, O., Dileep, V., Milo, B., Pao, P., Woolf, H., & Tsai, L. (2024) · Glia · doi:10.1002/glia.24485 · Cited by 52
“TREM2 has been shown to play a role in developmental synaptic pruning in the mouse brain, and microglia have been reported to engage in inappropriate synaptic pruning in adult AD model mice (Filipello et al., 2018; Hong et al., 2016; Salter & Stevens, 2017).”
BackgroundWang, Q., Liu, J., Zhang, Y., Li, Z., Zhao, Z., Jiang, W., Zhao, J., Hou, L., & Wang, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103369 · Cited by 54
“Hong et al. found that in an AD mouse model, inhibition of microglial CR3 reduced the number of phagocytic microglia, and the degree of synapse loss [62].”
BackgroundRedox regulation, protein S-nitrosylation, and synapse loss in Alzheimer’s and related dementias
Oh, C.-K., Nakamura, T., Zhang, X., & Lipton, S. A. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.013 · Cited by 56
Mizoguchi, Y., & Monji, A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00069 · Cited by 47
“…cytokines (such as TNFα, IL-6), nitric oxide (NO) and neurotrophic factors (such as brain-derived neurotrophic factor, BDNF) when they are activated in response to immunological stimuli (Kato et al., 2013; Monji et al., 2013, 2014; Mizoguchi et al., 2014a; Smith and Dragunow, 2014).”
BackgroundAmylin receptor ligands reduce the pathological cascade of Alzheimer's disease
Zhu, H., Xue, X., Wang, E., Wallack, M., Na, H., Hooker, J. M., Kowall, N. W., Tao, Q., Stein, T. D., Wolozin, B. L., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.030 · Cited by 51
“However, increasing evidence suggests that while pathological deposits are good diagnostic markers for disease, they might not be the pathologically toxic species (Cohen et al., 2009; Hong et al., 2016).”
BackgroundSmith, L. A., & McMahon, L. L. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.014 · Cited by 49
“, 2013), and spine density remains intact by 9 months, these data may suggest the increased glial response is protective at these ages, prior to a cytotoxic switch which could mediate synapse loss (Hong et al., 2016).”
Unger, M. S., Marschallinger, J., Kaindl, J., Klein, B., Johnson, M., Khundakar, A. A., Roßner, S., Heneka, M. T., Couillard‐Despres, S., Rockenstein, E., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.017 · Cited by 47
Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro
Muth, C., Hartmann, A., Sepulveda-Falla, D., Glatzel, M., & Krasemann, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00181 · Cited by 48
Microglia: The Brain's First Responders.
Bilbo, S. D., & Stevens, B. (2017) · PubMed Central · Cited by 61
Self-citationZhong, Q., Zou, Y., Liu, H., Chen, T., Zheng, F., Huang, Y., Chen, C., & Zhang, Z. (2020) · Molecular Brain · doi:10.1186/s13041-020-0559-8 · Cited by 46
Stress and Alzheimer’s disease: A senescence link?
Lyons, C. E., & Bartolomucci, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.010 · Cited by 57
“However, activation of C3aR1 has also been shown to promote early synapse loss (Hong et al., 2016), cognitive decline (Shi et al.”
BackgroundMongan, D., Sabherwal, S., Susai, S. R., Föcking, M., Cannon, M. D., & Cotter, D. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.036 · Cited by 48
Role of Macrophages and Microglia in Zebrafish Regeneration
Var, S. R., & Byrd-Jacobs, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134768 · Cited by 58
Engulfed by Glia: Glial Pruning in Development, Function, and Injury across Species
Raiders, S. A., Han, R. T., Scott‐Hewitt, N., Kucenas, S., Lew, D., Logan, M. A., & Singhvi, A. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1660-20.2020 · Cited by 43
“For example, microglial synaptic targeting not only occurs in development, but also in vulnerable brain regions of several disease models (Neher et al., 2012; Y. Wang et al., 2015; Hong et al., 2016; Schafer et al., 2016; Vasek et al., 2016; Werneburg et al., 2020).”
BackgroundMicroglia Phenotypes Converge in Aging and Neurodegenerative Disease
Candlish, M., & Hefendehl, J. K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.660720 · Cited by 51
“suggest that microglia play a beneficial role in AD, microglia themselves contribute to synaptic and neuronal loss in AD (48).”
BackgroundMu, X., Liu, J., Wang, H., Yuan, L., Wang, C., Li, Y., & Qiu, J. Y. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c01531 · Cited by 47
Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice
Itoh, N., Itoh, Y., Meyer, C., Suen, T. T., Cortez-Delgado, D., Lomeli, M. R., Wendin, S., Somepalli, S. S., Golden, L. C., MacKenzie‐Graham, A. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41723-7 · Cited by 61
“Indeed, astrocytes play a role in synaptic loss and function through direct effects on maintaining synaptic health and through indirect effects on microglia and subsequent synaptic engulfment and plasticity 30,45,81 – 86 .”
BackgroundSpatial proteomics of Alzheimer’s disease-specific human microglial states
Mrdjen, D., Cannon, B. J., Amouzgar, M., Kim, Y., Liu, C. C., Vijayaragavan, K., Fullaway, C. C., Spence, A., McCaffrey, E., Bharadwaj, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02203-w · Cited by 71
Jha, S. K., Jha, N. K., Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., & Kumar, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160623 · Cited by 53
A review of human diseases caused or exacerbated by aberrant complement activation
McGeer, P. L., Lee, M., & McGeer, E. G. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.017 · Cited by 51
Complement system biomarkers in epilepsy
Kopczynska, M., Zelek, W. M., Vespa, S., Touchard, S., Wardle, M., Loveless, S., Thomas, R. H., Hamandi, K., & Morgan, B. P. (2018) · Seizure · doi:10.1016/j.seizure.2018.05.016 · Cited by 54
In Vivo Imaging of Microglia With Multiphoton Microscopy
Hierro-Bujalance, C., Bacskai, B. J., & Garcia-Alloza, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00218 · Cited by 46
Ferro, A., Sheeler, C., Rosa, J.-G., & Cvetanovic, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.016 · Cited by 46
Olsen, I., & Singhrao, S. K. (2019) · Journal of Oral Microbiology · doi:10.1080/20002297.2019.1676486 · Cited by 58
“Collectively, they may also cause loss of synapses [65,68] if CR1 functionality is suppressed by its poly-”
BackgroundMakinde, H. M., Winter, D. R., Procissi, D., Mike, E. V., Stock, A. D., Kando, M. J., Gadhvi, G. T., Droho, S., Bloomfield, C. L., Dominguez, S. T., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00230 · Cited by 47
“A number of genes comprising the “NP-SLE signature” are highly relevant to microglial function [Furin (52), Vcam-1 (53), Cxcl16 (54), C4b (55)], aging [Sp100 (56)], and activation [ApoD (57)].”
BackgroundGlial remodeling enhances short-term memory performance in Wistar rats
De Luca, S. N., Soch, A., Sominsky, L., Nguyen, T.-X., Bosakhar, A., & Spencer, S. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1729-4 · Cited by 46
Bollinger, J. L., Horchar, M. J., & Wohleb, E. S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0720-1 · Cited by 45
Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease
Kim, A., García-García, E., Straccia, M., Comella-Bolla, A., Miguez, A., Masana, M., Alberch, J., Canals, J. M., & Rodríguez, M. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00163 · Cited by 46
Li, S., Li, B., Zhang, L., Zhang, G.-F., Sun, J., Ji, M., & Yang, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106814 · Cited by 51
Self-citationControl of Innate Immunity by Sialic Acids in the Nervous Tissue
Liao, H., Klaus, C., & Neumann, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155494 · Cited by 49
“Previous research suggested that inappropriate over-activation of the classical complement cascade mediates synaptic elimination by microglial phagocytosis early in AD animal models [40,148].”
BackgroundBevan, R. J., Hughes, T. R., Williams, P. A., Good, M. A., Morgan, B. P., & Morgan, J. E. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01094-2 · Cited by 49
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer’s Disease
Huang, W., Xia, Q., Zheng, F., Zhao, X. L., Ge, F., Xiao, J., Liu, Z., Shen, Y., Ye, K., Wang, D., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221064 · Cited by 51
“A -induced microglial phagocytosis of synapses was proven to be dependent on the complement pathway [79, 95].”
BackgroundC5aR1 signaling promotes region‐ and age‐dependent synaptic pruning in models of Alzheimer's disease
Gómez-Arboledas, Á., Fonseca, M. I., Kramár, E. A., Chu, S., Schartz, N. D., Selvan, P., Wood, M. A., & Tenner, A. J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13682 · Cited by 54
“13,21,23,43 To investigate if C3 tagging would correlate with the VGlut1 pre-synaptic density changes observed at 10 months of age in the Arc and Arc-C5aR1KO (vs. WT) mice in the CA3-SL region, sections were immunostainedforC3andVGlut1,andquantificationstudieswerecar-ried out with Imaris software…”
BackgroundMethodInfluentialAlzheimer’s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response
Wang, Z., Zhang, L., & Qin, C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00857-6 · Cited by 65
Disease-associated microglia in neurodegenerative diseases: Friend or foe?
Cheng, Y.-H., & Ho, M. S.-C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003426 · Cited by 65
“The parallels between DAM and PAM support the concept that genes expressed during development are reactivated in aging and degeneration [43].”
Extracellular heat shock proteins in neurodegenerative diseases: New perspectives
Lyon, M. S., & Milligan, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134462 · Cited by 45
Transcriptional Networks of Microglia in Alzheimer’s Disease and Insights into Pathogenesis
Chew, G., & Petretto, E. G. (2019) · Genes · doi:10.3390/genes10100798 · Cited by 51
Schmitz, T. W., Soreq, H., Poirier, J., & Spreng, R. N. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1184-19.2019 · Cited by 45
“Finally, quantification of CSF C3 is possible with ELISAs, and has been successfully implemented in the ADNI-1 cohort (Bonham et al., 2016; Hu et al., 2016), but not the ADNI-GO/ADNI-2 cohort used for the current study.”
MethodSystemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing
Manabe, T., Rácz, I., Schwartz, S., Oberle, L., Santarelli, F., Emmrich, J. V., Neher, J. J., & Heneka, M. T. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15491 · Cited by 44
“This microglial synaptic pruning often, but not always, requires activation of the complement pathway and the subsequent tagging of synapses for microglial recognition (Dejanovic et al., 2018; Hong et al., 2016; Schafer et al., 2012; Weinhard et al., 2018).”
BackgroundGenetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Targeting complement in neurodegeneration: challenges, risks, and strategies
Zelek, W. M., & Morgan, B. P. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.006 · Cited by 43
Cangalaya, C., Wegmann, S., Sun, W., Diez, L., Gottfried, A., Richter, K., Stoyanov, S., Pakan, J. M. P., Fischer, K., & Dityatev, A. E. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.023 · Cited by 49
ATM-deficiency-induced microglial activation promotes neurodegeneration in ataxia-telangiectasia
Lai, J. F., Demirbas, D., Kim, J., Jeffries, A. M., Tolles, A. K., Park, J., Chittenden, T. W., Buckley, P. G., Yu, T. W., Lodato, M. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113622 · Cited by 46
“36,37 To assess whether A-T cerebellar microglia share additional features associated with microglia in aging and other neurodegenerative disorders, we compared the upregulated genes in A-T cerebellar microglia with three gene sets: markers of aged human microglia, AD-associated microglia markers…”
ResultMicroglia phagocytic mechanisms: Development informing disease
Beiter, R. M., Sheehan, P. W., & Schafer, D. P. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102877 · Cited by 44
“…clearance of synaptic material by microglia contributes to neurodegeneration in aging [30], mouse models relevant to Alzheimer’s disease (AD) [31 e 34], amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD) [35,36], West Nile virus (WNV) infection-induced neurodegeneration [37],…”
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Singh, R., Panghal, A., Jadhav, K., Thakur, A., Verma, R. K., Singh, C., Goyal, M., Kumar, J., & Namdeo, A. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04256-8 · Cited by 55
“Furthermore, the complement system can be activated by enhancing the phagocytic activity of microglia, which eventually may result in erroneous synaptic pruning [102].”
Incontro, S., Musella, M. L., Sammari, M., Scala, C. D., Fantini, J., & Debanne, D. (2024) · Physiological Reviews · doi:10.1152/physrev.00004.2024 · Cited by 59
Monda, A., Torre, M. E. L., Messina, A., Maio, G. D., Monda, V., Moscatelli, F., Stefano, M. D., Marra, M. L., di Padova, M., Dipace, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425816 · Cited by 51
“In recent years, microglial activation was identi fi ed as one of the main features of neurodegenerative diseases (26, 27).”
BackgroundModulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Fiala, M., Kooij, G., Wagner, K., Hammock, B., & Pellegrini, M. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44
Yuyama, K., Takahashi, K., Usuki, S., Mikami, D., Sun, H., Hanamatsu, H., Furukawa, J., Mukai, K., & Igarashi, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-53394-w · Cited by 49
Curdlan Prevents the Cognitive Deficits Induced by a High-Fat Diet in Mice via the Gut-Brain Axis
Yang, X., Zheng, M., Hao, S., Shi, H., Lin, D., Chen, X., Becvarovski, A., Pan, W., Zhang, P., Hu, M., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00384 · Cited by 49
Jo, D., Kim, B. C., Cho, K. A., & Song, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132773 · Cited by 47
Rupprecht, R., Pradhan, A. K., Kufner, M., Brunner, L.-M., Nothdurfter, C., Wein, S., Schwarzbach, J. V., Puig-Bosch, X., Rupprecht, C., & Rammes, G. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01532-3 · Cited by 55
Central Nervous System Macrophages in Health and Disease
Hove, H. V., Feo, D. D., Greter, M., & Becher, B. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-041334 · Cited by 53
Zhu, K., Sun, J., Kang, Z., Zou, Z., Wu, G., & Wang, J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00613 · Cited by 43
“The complement components are highly involved in the process of phagocytosis (Tyler and Boulanger, 2012) and C3/C3R pathway not only participates in the process of microglial phagocytosis but also plays an important role in the priming of microglia (Fu et al., 2012; Ramaglia et al., 2012; Hong et al., 2016).”
BackgroundIida, T., Yoshikawa, T., Kárpáti, A., Matsuzawa, T., Kitano, H., Mogi, A., Harada, R., Naganuma, F., Nakamura, T., & Yanai, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.081 · Cited by 44
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia
Zorina, Y., Stricker, J., Caggiano, A. O., & Button, D. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-27559-y · Cited by 43
Iulita, M. F., Ganesh, A., Pentz, R., Flores Aguilar, L., Gubert, P., Ducatenzeiler, A., Christie, S., Wilcock, G. K., & Cuello, A. C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180970 · Cited by 43
Madrid-Gambín, F., Föcking, M., Sabherwal, S., Heurich, M., English, J. A., O’Gorman, A., Suvitaival, T., Ahonen, L. L., Cannon, M. D., Lewis, G., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.018 · Cited by 49
“Together, the data provide a link among phospholipid binding proteins, (apo)lipoproteins, complement, and coagulation, and they support growing literature implicating these processes in neuroinflammation and neurodegeneration (77,81).”
ResultmiR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q
Xu, N., Li, A.-D., Ji, L.-L., Yao, Y., Wang, Z., & Tong, L. (2019) · European Journal of Histochemistry · doi:10.4081/ejh.2019.3008 · Cited by 48
Complement C5 Contributes to Brain Injury After Subarachnoid Hemorrhage
van Dijk, B. J., Meijers, J. C. M., Kloek, A. T., Knaup, V. L., Rinkel, G. J. E., Morgan, B. P., van der Kamp, M. J., Osuka, K., Aronica, E., Ruigrok, Y. M., et al. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00757-0 · Cited by 44
“Synaptic pruning by microglia occurs during development, but also in diseases such as glaucoma and Alzheimer’s disease and after viral infection [41, 43, 44].”
BackgroundPTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy
Benetatos, J., Bennett, R. E., Evans, H. T., Ellis, S. A., Hyman, B. T., Bodea, L.-G., & Götz, J. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02151-9 · Cited by 43
Hou, L., Qu, X., Qiu, X., Huang, R., Zhao, X., & Wang, Q. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01823-3 · Cited by 49
Li, L., Liang, J., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.020 · Cited by 48
Complement in Neurologic Disease
Propson, N. E., Gedam, M., & Zheng, H. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-031620-113409 · Cited by 43
The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases
Triviño, J. J., & von Bernhardi, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104982 · Cited by 43
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00862-z · Cited by 45
Ghosh, P., Singh, R., Ganeshpurkar, A., Pokle, A. V., Singh, R. B., Singh, S. K., & Kumar, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105212 · Cited by 43
The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43
“In regards to inflammatory processes and synaptic health, one study demonstrated that microglia contribute to synaptic loss through Aβ-induced microglia phagocytosis of synaptic contents [144].”
BackgroundSinha, A., Kushwaha, R., Molesworth, K., Mychko, O., Makarava, N., & Baskakov, I. V. (2021) · Cells · doi:10.3390/cells10071728 · Cited by 42
Neuronal Cell Adhesion Molecules May Mediate Neuroinflammation in Autism Spectrum Disorder
Eve, M., Gandawijaya, J., Yang, L., & Oguro‐Ando, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.842755 · Cited by 47
“In AD models, microglia respond more readily to Aβ, producing increased proinflammatory cytokines that degrade neuronal synapses, leading to cognitive decline (155).”
BackgroundInfluentialIweka, C. A., Seigneur, E. M., Latif‐Hernandez, A., Paredes, S. H., Cabrera, M., Blacher, E., Tsai, C. A., Longo, F. M., de Lecea, L., & Andreasson, K. I. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02727-8 · Cited by 50
Wright, A. L., Konen, L. M., Mockett, B. G., Morris, G. P., Singh, A., Burbano, L. E., Milham, L. T., Hoang, M., Zinn, R., Chesworth, R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00632-5 · Cited by 50
Xie, M., Pallegar, P. N., Parusel, S., Nguyen, A. T., & Wu, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00665-w · Cited by 45
“The molecular components that mediate synaptic pruning include completement [197], CX3CR1 [199], and TREM2 [200, 201].”
BackgroundJohnston, K. G., Berackey, B. T., Tran, K. M., Gelber, A., Yu, Z., MacGregor, G. R., Mukamel, E. A., Tan, Z., Green, K. N., & Xu, X. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02651-0 · Cited by 58
“…[13], regulation of development and spread of Tau pathology [14], destruction of perineuronal nets [15, 16], and synaptic and neuronal loss [15, 17 – 20], though the role of microglia in suppressing or aggravating impacts of AD is currently unclear, and may vary with disease progression [21].”
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.